000 | 01201 a2200325 4500 | ||
---|---|---|---|
005 | 20250514002418.0 | ||
264 | 0 | _c20010906 | |
008 | 200109s 0 0 eng d | ||
022 | _a0168-1656 | ||
024 | 7 |
_a10.1016/s0168-1656(01)00238-3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFonjallaz , P | |
245 | 0 | 0 |
_aRecombinant hCG (OVIDREL) and recombinant interferon-(beta)1a (REBIF). (No. 13 in a series of articles to promote a better understanding of the use of genetic engineering). _h[electronic resource] |
260 |
_bJournal of biotechnology _cMay 2001 |
||
300 |
_a279-81 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCHO Cells |
650 | 0 | 4 |
_aChorionic Gonadotropin _xgenetics |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aCricetinae |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInfertility, Female _xdrug therapy |
650 | 0 | 4 |
_aProtein Engineering _xmethods |
650 | 0 | 4 |
_aRecombinant Proteins _xgenetics |
700 | 1 | _aLoumaye, E | |
773 | 0 |
_tJournal of biotechnology _gvol. 87 _gno. 3 _gp. 279-81 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0168-1656(01)00238-3 _zAvailable from publisher's website |
999 |
_c11341578 _d11341578 |